What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Notch Signaling in Neurogenesis: Mechanisms and Roles

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to Notch Signaling in Neurogenesis

What is Notch Signaling?

Notch signaling is an evolutionarily conserved cell–cell communication pathway that controls cell fate decisions in virtually all metazoan tissues. Unlike most signaling pathways that rely on diffusible ligands, Notch signaling operates through direct membrane contact between adjacent cells. The pathway derives its name from the "notched" wing phenotype observed in Drosophila melanogaster mutants over a century ago, and its core molecular logic has remained remarkably conserved from flies to humans.

In the context of neurogenesis—the process by which neural stem cells generate functional neurons—Notch signaling serves as a master regulator of progenitor maintenance, fate specification, and differentiation timing. During embryonic development, Notch activity keeps neural stem cells in a proliferative, undifferentiated state. In the adult brain, it maintains quiescent neural stem cell pools and regulates the balance between self-renewal and differentiation. Disruption of Notch signaling is implicated in neurodevelopmental disorders, brain tumors, and age-related cognitive decline, making it a pathway of central importance in developmental neuroscience.

Neurogenesis Overview

Neurogenesis encompasses the entire sequence from neural stem cell division to the integration of a mature, functional neuron into a neural circuit. This process occurs in two major phases: embryonic neurogenesis, which builds the nervous system, and adult neurogenesis, which continues in restricted niches such as the subventricular zone (SVZ) and the dentate gyrus of the hippocampus.

The fundamental challenge in neurogenesis is maintaining a balance: the brain must generate enough neurons to build functional circuits, but it must not exhaust its progenitor pools prematurely. Notch signaling is the primary mechanism that achieves this balance through a process called lateral inhibition, where differentiating cells signal to their neighbors to remain undifferentiated. This ensures that at any given time, only a fraction of progenitor cells commit to neuronal differentiation while the remainder stay as a renewable stem cell population. For a broader overview of the pathway's core logic, see the Notch Signaling Pathway.

Core Components of the Notch Pathway

Notch Receptors and Ligands

Mammals possess four Notch receptors (Notch1–Notch4), each encoded by a distinct gene (NOTCH1–NOTCH4). These are single-pass type I transmembrane proteins synthesized as ~300 kDa precursors. The mature receptor is a heterodimer formed by proteolytic cleavage (see S1 cleavage below) and held together by non-covalent calcium-dependent interactions.

Each Notch receptor contains several functional domains:

Extracellular domain (NECD): Contains 29–36 epidermal growth factor (EGF)-like repeats responsible for ligand binding, followed by three Lin12-Notch repeats (LNR) that prevent ligand-independent activation.
Transmembrane domain: A single membrane-spanning helix containing the S2 and S3 cleavage sites.
Intracellular domain (NICD): Contains a RAM domain, seven ankyrin (ANK) repeats, a nuclear localization signal (NLS), a transactivation domain (TAD), and a PEST sequence that controls protein stability.

The canonical ligands are Delta-like (Dll1, Dll3, Dll4) and Jagged (Jag1, Jag2) in mammals, all of which are also transmembrane proteins. The DSL domain (Delta/Serrate/Lag-2) is required for receptor binding, while the DOS domain (Delta and OSM-11-like) modulates binding affinity. In the nervous system, Dll1 and Jag1 are the predominant ligands expressed by differentiating neurons and glia.

Intracellular Signaling Cascade

The downstream effectors of Notch signaling form a relatively simple cascade compared to other pathways. The central transcription factor is CSL (CBF1/RBP-Jκ in mammals, Suppressor of Hairless in Drosophila, Lag-1 in C. elegans; also called RBPJ). In the absence of Notch signaling, CSL binds to DNA and recruits co-repressors such as SMRT/NCoR and histone deacetylases (HDACs), maintaining target genes in a repressed state.

When NICD enters the nucleus, it displaces co-repressors and recruits the Mastermind-like (MAML) family of co-activators. This NICD–CSL–MAML ternary complex then recruits additional co-activators including p300/CBP, which acetylates histones and promotes transcriptional activation. The primary transcriptional targets are the Hes (Hairy/Enhancer of Split) and Hey (Hes-related with YRPW motif) gene families, which encode basic helix-loop-helix (bHLH) transcription factors. Hes1 and Hes5 are the most important in neurogenesis; they repress proneural gene expression (such as Ascl1 and Neurogenin2) and thereby maintain progenitor identity.

Mechanism of Notch Activation

Ligand-Receptor Interaction

Notch signaling is a juxtacrine system: it requires direct physical contact between a signal-sending cell expressing a ligand and a signal-receiving cell expressing a receptor. This is fundamentally different from paracrine or endocrine signaling where ligands diffuse through the extracellular space.

The activation process begins when a ligand on one cell engages a Notch receptor on an adjacent cell. This interaction is mediated by the EGF repeats 11–12 of Notch and the DSL domain of the ligand. Importantly, the ligand must be presented in the correct orientation and with appropriate post-translational modifications. The EGF repeats of Notch are modified by O-fucose glycosylation, catalyzed by POFUT1, and further elongated by Fringe family glycosyltransferases (Lunatic Fringe, Manic Fringe, Radical Fringe). Fringe modification of Notch enhances its sensitivity to Delta ligands while reducing sensitivity to Jagged ligands, providing a mechanism for differential signaling outcomes.

Ligand binding induces a conformational change in the Notch extracellular domain, exposing the S2 cleavage site. This site is cleaved by ADAM metalloproteases, primarily ADAM10 (and ADAM17 in some contexts). S2 cleavage removes most of the extracellular domain, leaving a membrane-tethered intermediate called NEXT (Notch extracellular truncation).

Gamma-Secretase Cleavage

The NEXT fragment becomes a substrate for the γ-secretase complex, a multi-subunit intramembrane protease. The catalytic component is presenilin (PSEN1 or PSEN2), with nicastrin, APH-1, and PEN-2 as essential cofactors. γ-Secretase cleaves NEXT at the S3 site within the transmembrane domain, releasing the soluble NICD into the cytoplasm.

This cleavage occurs at a specific position approximately 12 amino acids into the transmembrane domain. The S3 cleavage is unusual because it occurs within the lipid bilayer, and γ-secretase exhibits "sloppy" proteolysis, generating NICD species of slightly varying lengths. The stability and signaling strength of NICD are influenced by this cleavage position, with longer forms being more stable.

The entire process from ligand binding to NICD release occurs within minutes, making Notch one of the fastest transcriptional signaling pathways. This speed is essential for the dynamic cell fate decisions that occur during neurogenesis.

NICD Nuclear Function

After release, NICD translocates to the nucleus via its NLS sequences. Nuclear import is mediated by importin-α/β machinery. Once in the nucleus, NICD binds CSL through its RAM domain, with the ANK repeats providing additional contacts. This binding displaces co-repressors and allows MAML recruitment.

The NICD–CSL–MAML complex activates transcription of target genes. The primary targets in neural progenitors are Hes1, Hes5, and Hey1/2. Hes proteins form homodimers or heterodimers that bind to N-box sequences (CACNAG) in the promoters of proneural genes, recruiting the co-repressor TLE/Groucho to silence them.

NICD signaling is terminated by phosphorylation of the PEST domain by CDK8 and other kinases, which triggers ubiquitination by the E3 ligase FBXW7 and subsequent proteasomal degradation. The half-life of NICD is typically 1–2 hours, which sets the timescale for Notch signaling dynamics. This rapid turnover is critical: sustained Notch signaling requires continuous ligand stimulation, allowing cells to respond quickly to changes in their environment.

Notch in Neural Stem Cell Maintenance

Role in Embryonic Neurogenesis

During embryonic development, neural stem cells (also called radial glial cells in the developing cortex) line the ventricular zone of the neural tube. These cells undergo asymmetric divisions to generate one stem cell and one more committed progenitor (intermediate progenitor cell) or one neuron. Notch signaling is the key regulator of this process.

The mechanism operates through lateral inhibition. When a neural stem cell commits to differentiation, it upregulates expression of Delta ligands (particularly Dll1). These ligands activate Notch receptors on neighboring stem cells, which respond by upregulating Hes1 and Hes5 expression. Hes proteins repress proneural genes such as Ascl1 (Mash1) and Neurog2 (Neurogenin2), preventing those neighbors from differentiating. The result is a salt-and-pepper pattern of differentiating cells surrounded by undifferentiated progenitors.

The importance of Notch in this process is demonstrated by loss-of-function studies. Conditional knockout of Notch1 in the developing mouse cortex causes premature differentiation of radial glial cells into neurons, depleting the progenitor pool and resulting in severe cortical hypoplasia. Conversely, constitutive activation of Notch signaling prevents neurogenesis entirely, locking cells in a progenitor state.

Notch signaling also regulates the mode of progenitor division. High Notch activity promotes symmetric self-renewing divisions (expanding the progenitor pool), while low Notch activity permits asymmetric divisions that generate neurons. This is achieved in part through regulation of the spindle orientation machinery and through control of cell cycle length. Notch-active progenitors have shorter cell cycles, allowing rapid expansion of the progenitor pool during early neurogenesis.

Adult Neurogenesis and Quiescence

In the adult brain, neurogenesis persists in two main regions: the subventricular zone (SVZ) lining the lateral ventricles and the subgranular zone (SGZ) of the hippocampal dentate gyrus. In both regions, Notch signaling maintains the quiescent neural stem cell (qNSC) population.

Adult qNSCs express high levels of Notch1 and Notch2. These cells are largely dormant, dividing rarely, but they can be activated to enter the cell cycle and generate neurons. Notch signaling maintains quiescence by promoting expression of cell cycle inhibitors such as p21 and p27, and by suppressing activation markers. When Notch signaling is experimentally ablated in adult NSCs, the quiescent pool is depleted as cells either differentiate or undergo apoptosis.

The niche provides the ligands that maintain qNSC quiescence. In the SVZ, ependymal cells and transit-amplifying cells express Dll1 and Jag1, activating Notch on adjacent qNSCs. In the SGZ, endothelial cells and mature granule neurons provide Jag1 signals. This niche-dependent signaling ensures that stem cells remain quiescent only when they are in the appropriate microenvironment.

Notch signaling also regulates the reactivation of qNSCs. During aging, Notch activity declines, contributing to the age-related decrease in neurogenesis. Pharmacological activation of Notch signaling in aged mice partially restores neurogenesis, suggesting that Notch is a limiting factor for adult neurogenesis. However, excessive Notch activation prevents activation, so the pathway must be finely tuned. The balance between quiescence and activation is further modulated by crosstalk with other pathways, including the Wnt Signaling Pathway, which promotes activation and neuronal differentiation.

Notch in Neuronal Differentiation and Fate Specification

Lateral Inhibition and Neuroblast Selection

Lateral inhibition is the canonical mechanism by which Notch signaling selects which cells will differentiate into neurons. This process is best understood in the Drosophila neuroectoderm, where it selects neuroblasts from a field of equivalent cells, but the same logic operates in vertebrate neurogenesis.

The process begins with small stochastic differences in proneural gene expression among a group of equivalent progenitor cells. Cells with slightly higher proneural activity (e.g., Ascl1 or Neurog2) upregulate Delta ligands. The increased Delta on these cells activates Notch on their neighbors, suppressing proneural gene expression in those neighbors. This creates a feedback loop: the cell with high proneural activity becomes a "sender" that differentiates into a neuron, while neighbors become "receivers" that maintain progenitor identity.

This system has several important properties:

Bistability: The feedback loop creates two stable states—high proneural/low Notch (differentiating) and low proneural/high Notch (progenitor). Intermediate states are unstable.
Spatial patterning: The result is a regular pattern of differentiating cells separated by undifferentiated cells, ensuring that the progenitor pool is not depleted.
Temporal regulation: The decision to differentiate is made cell-by-cell, allowing continuous neurogenesis over an extended developmental period.

In the vertebrate cortex, this process is dynamic. Live imaging studies show that neural progenitors exhibit oscillatory expression of Hes1 and Ascl1. Hes1 expression oscillates with a period of 2–3 hours, driven by negative feedback (Hes1 represses its own promoter). These oscillations maintain progenitors in a poised state, and the decision to differentiate occurs when oscillations are dampened and Ascl1 expression becomes sustained.

Gliogenesis and Astrocyte Specification

Notch signaling is not only involved in neurogenesis but also controls the switch from neurogenesis to gliogenesis. During development, the neuroepithelium first generates neurons and then switches to producing glial cells (astrocytes and oligodendrocytes). Notch signaling promotes this gliogenic switch.

The mechanism involves the timing of Notch target gene expression. Early in development, Notch activation promotes expression of Hes1 and Hes5, which maintain progenitors and suppress neuronal differentiation. Later, Notch signaling also induces expression of glial fate determinants, particularly the transcription factors NFIA, NFIB, and Sox9. These factors cooperate with STAT signaling (activated by cytokines such as CNTF and LIF) to activate glial-specific genes such as GFAP.

Notch promotes astrocyte specification through a direct mechanism: NICD–CSL complexes bind to the GFAP promoter and activate its expression in cooperation with STAT3. This requires the prior "priming" of the GFAP promoter by epigenetic modifications that occur during the neurogenic-to-gliogenic switch. The timing of this switch is regulated by the progressive accumulation of repressive marks on neuronal genes and activating marks on glial genes.

Notch also influences oligodendrocyte development, though the role is more complex. Notch activation initially promotes oligodendrocyte precursor cell (OPC) specification but inhibits their terminal differentiation into mature oligodendrocytes. This dual role is mediated by different downstream effectors: Hes5 promotes OPC specification, while sustained Notch signaling represses myelin gene expression through Hes1 and Hey1. The precise outcome depends on the cellular context and the stage of differentiation.

For a more detailed discussion of how Notch controls cell fate decisions in the developing nervous system, see Notch Signaling and Neuronal Development.

Experimental Methods to Study Notch Signaling

Genetic Models

The study of Notch signaling in neurogenesis relies heavily on genetic manipulation. Several approaches are commonly used:

Conditional knockout: The Cre-loxP system allows cell-type-specific deletion of Notch pathway genes. For example, crossing Nestin-Cre mice (which express Cre in neural progenitors) with Notch1 floxed mice deletes Notch1 specifically in the nervous system. This approach has revealed the essential role of Notch1 in maintaining neural progenitors.

Dominant-negative constructs: Expression of a dominant-negative MAML (dnMAML) blocks all CSL-dependent Notch signaling. This construct lacks the transactivation domain but retains the NICD-binding domain, so it competes with endogenous MAML and prevents transcriptional activation. dnMAML is useful for acute inhibition of Notch signaling in a temporally controlled manner.

Constitutive activation: Expression of NICD (the active intracellular domain) bypasses ligand-dependent activation and produces constitutive Notch signaling. This is achieved by expressing the NICD cDNA under a tissue-specific promoter. In neural progenitors, NICD expression prevents differentiation and maintains stem cell identity.

Knockdown approaches: Short hairpin RNA (shRNA) or short interfering RNA (siRNA) can transiently reduce expression of Notch pathway components. This is useful for acute experiments in cultured cells or organotypic slices where genetic knockout is impractical.

Pharmacological Inhibition

Pharmacological tools provide rapid, reversible inhibition of Notch signaling. The most widely used are γ-secretase inhibitors (GSIs), which block S3 cleavage and prevent NICD release.

DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester) is the most common GSI used in neurogenesis research. It is typically used at concentrations of 10–50 μM in cell culture and 10–100 mg/kg in animal models. DAPT treatment of neural progenitor cultures rapidly reduces Hes1 and Hes5 expression within 2–4 hours and promotes neuronal differentiation within 24–48 hours.

Other GSIs include:

Compound E: More potent than DAPT, used at 1–10 μM in culture.
LY-411575: A potent GSI used in vivo, often at 1–10 mg/kg.
Dibenzazepine (DBZ): Used at 5–20 μM in culture.

GSIs have limitations. They inhibit all γ-secretase substrates, including amyloid precursor protein (APP) and other transmembrane proteins, so effects may not be solely due to Notch inhibition. Additionally, chronic GSI treatment causes gastrointestinal toxicity due to inhibition of Notch signaling in intestinal stem cells.

Blocking antibodies: More specific inhibition can be achieved with antibodies that block ligand-receptor interaction. Anti-Dll4 antibodies (e.g., demcizumab) and anti-Notch1 antibodies (e.g., brontictuzumab) are available, though their use in neurogenesis research is less common than GSIs.

Notch Reporter Systems

Reporter assays allow visualization and quantification of Notch pathway activity in living cells or tissues.

CSL-luciferase reporters: A synthetic promoter containing multiple CSL binding sites upstream of firefly luciferase is transfected into cells. Notch activity drives luciferase expression, which is quantified by luminescence. This is a sensitive, quantitative assay for pathway activity.

TP1-GFP reporter: This transgenic mouse line expresses GFP under the control of a CSL-responsive promoter. GFP expression marks cells with active Notch signaling, allowing visualization of Notch-active cells in tissue sections or live imaging. This reporter has been used extensively to identify neural stem cells in the adult brain.

Hes5-GFP reporter: Similar to TP1-GFP, this reporter uses the Hes5 promoter to drive GFP expression. It is more specific for neural progenitors and is commonly used to identify Notch-responsive cells in the developing and adult nervous system.

Notch intracellular domain immunostaining: Antibodies against the cleaved NICD (e.g., cleaved Notch1 Val1744 antibody) detect the active form of Notch. This allows assessment of Notch activation at single-cell resolution in fixed tissue.

Live Imaging

Time-lapse imaging of Notch signaling dynamics has revealed important features of the pathway. Using fluorescent reporters and confocal or two-photon microscopy, researchers can track individual neural progenitors over hours to days and correlate Notch activity with cell fate decisions.

For example, live imaging of the developing mouse cortex has shown that neural progenitors exhibit dynamic changes in Notch activity as they divide and differentiate. Cells that maintain high Notch activity continue to self-renew, while cells with declining Notch activity differentiate into neurons. This approach has also revealed the oscillatory nature of Hes1 expression and its role in maintaining progenitor plasticity.

Common Pitfalls and Misconceptions

Notch is Not a Simple Switch

A common misconception is that Notch signaling is a binary on/off system. In reality, Notch signaling operates across a continuum of activity levels, and the biological outcome depends on signal strength, duration, and dynamics.

Different levels of Notch activation produce different outcomes. Low-level Notch activity may maintain progenitor identity, while high-level activity may promote gliogenesis or even induce cell cycle exit. The dose-response curve is not linear, and there are thresholds that determine which target genes are activated. For example, Hes1 is activated at lower NICD levels than Hey1, so different target genes are expressed at different signaling intensities.

The dynamics of Notch signaling also matter. Oscillatory Notch activity (as seen in Hes1 expression) maintains progenitors in a plastic state, while sustained Notch activity locks cells into a particular fate. This distinction is lost in experiments that use constitutive NICD expression, which produces sustained high-level signaling that may not recapitulate physiological conditions.

Context-Dependent Outcomes

Notch signaling outcomes are highly context-dependent. The same ligand-receptor interaction can produce different results depending on the cell type, developmental stage, and epigenetic state of the receiving cell.

For example, Notch activation in early neural progenitors maintains stemness, but Notch activation in committed neuronal precursors can promote apoptosis or alter neuronal subtype identity. Similarly, Notch promotes astrocyte differentiation at later developmental stages but not at earlier stages, because the GFAP promoter is not yet accessible.

The response to Notch signaling also depends on the specific receptor and ligand involved. Notch1 and Notch2 have partially redundant but also distinct functions in neural progenitors. Dll1 and Jag1 can produce different signaling outcomes due to differential Fringe modification of receptors. These nuances are often overlooked in simplified models of the pathway.

Technical Artifacts in Experiments

Several technical pitfalls can confound experiments on Notch signaling:

Off-target effects of GSIs: γ-secretase has many substrates beyond Notch, including APP, cadherins, and ErbB4. GSI treatment therefore affects multiple pathways, and phenotypes may not be solely due to Notch inhibition. Control experiments with γ-secretase-independent Notch inhibition (e.g., dnMAML) are essential.

Overexpression artifacts: Transfection of NICD or ligand constructs often produces supraphysiological expression levels that do not reflect endogenous signaling. This can lead to non-physiological outcomes, such as activation of genes that are not normally Notch targets.

Reporter limitations: Notch reporter lines may not capture all Notch activity. The TP1-GFP reporter, for example, only reports CSL-dependent signaling and may miss CSL-independent Notch functions. Additionally, GFP protein stability can produce a lag between transcriptional activity and visible fluorescence, complicating interpretation of dynamic experiments.

Cell culture artifacts: Notch signaling is highly sensitive to cell density and cell-cell contact. In dissociated cultures, the loss of cell contact can artifactually reduce Notch signaling. Conversely, high-density cultures may show elevated Notch activity. Standardizing cell density and using appropriate controls is critical.

Antibody specificity: Antibodies against NICD (e.g., cleaved Notch1 Val1744) are generally specific, but antibodies against full-length Notch or ligands can cross-react with other proteins. Validation with knockout or knockdown controls is essential.

Summary and Key Takeaways

Notch signaling is a fundamental regulator of neurogenesis, controlling the balance between stem cell maintenance and differentiation across development and in the adult brain. The pathway operates through direct cell-cell contact, with ligand-expressing cells activating Notch receptors on adjacent cells, leading to proteolytic release of NICD and transcriptional regulation of target genes.

The pathway's core logic is lateral inhibition: differentiating cells signal to their neighbors to remain undifferentiated, ensuring a renewable progenitor pool. This mechanism operates in both embryonic and adult neurogenesis, though with context-specific variations. Notch also controls the timing of neurogenesis and the switch to gliogenesis, making it a master regulator of neural development.

Understanding Notch signaling requires appreciation of its complexity: the pathway is not a simple switch but operates across a continuum of activity levels with dynamic, oscillatory behavior. Outcomes depend on cellular context, receptor-ligand combinations, and the epigenetic state of target genes. Experimental approaches must account for these complexities to produce meaningful results.

Frequently Asked Questions

What is the role of Notch signaling in neurogenesis?

Notch signaling maintains neural stem and progenitor cells in an undifferentiated, proliferative state. It prevents premature differentiation by repressing proneural genes, regulates the balance between self-renewal and differentiation through lateral inhibition, and controls the timing of neurogenesis and the switch to gliogenesis. In the adult brain, Notch maintains quiescent neural stem cell pools and regulates their activation.

How does Notch signaling work?

Notch signaling is a juxtacrine pathway requiring direct cell-cell contact. A ligand (Delta or Jagged) on one cell binds a Notch receptor on an adjacent cell, inducing a conformational change. This triggers sequential proteolytic cleavages by ADAM proteases (S2 cleavage) and γ-secretase (S3 cleavage), releasing the intracellular domain (NICD). NICD translocates to the nucleus, binds the CSL transcription factor, recruits co-activators including MAML, and activates target genes such as Hes1 and Hes5.

What happens when Notch signaling is inhibited?

Inhibition of Notch signaling in neural progenitors causes premature neuronal differentiation and depletion of the progenitor pool. In the developing cortex, this results in reduced brain size. In the adult brain, Notch inhibition activates quiescent neural stem cells but eventually depletes them. The specific phenotype depends on the timing and cell type of inhibition.

What are the main components of the Notch pathway?

The main components are: Notch receptors (Notch1–4), ligands (Dll1, Dll3, Dll4, Jag1, Jag2), the proteases that process the receptor (ADAM10/17 and γ-secretase complex), the transcription factor CSL/RBPJ, co-activators (MAML1–3), and downstream target genes (Hes and Hey families). Post-translational modifiers such as POFUT1 and Fringe glycosyltransferases also play important regulatory roles.

How is Notch signaling studied experimentally?

Common approaches include genetic knockout or knockdown (Cre-loxP, shRNA), constitutive activation (NICD overexpression), pharmacological inhibition (γ-secretase inhibitors like DAPT), reporter assays (CSL-luciferase, TP1-GFP, Hes5-GFP), and live imaging of Notch dynamics. Each approach has specific advantages and limitations that must be considered in experimental design.

Does Notch signaling have a role in adult neurogenesis?

Yes. Notch signaling maintains quiescent neural stem cells in the adult subventricular zone and hippocampal dentate gyrus. It prevents premature activation and depletion of the stem cell pool. Notch activity declines with age, contributing to reduced adult neurogenesis. The niche provides ligands that maintain Notch signaling in quiescent stem cells.

What is lateral inhibition in neurogenesis?

Lateral inhibition is the process by which a cell committed to neuronal differentiation signals to its neighbors to remain undifferentiated. The differentiating cell upregulates Delta ligand, which activates Notch receptors on adjacent cells. Notch activation in those neighbors represses proneural gene expression, preventing them from differentiating. This creates a regular pattern of differentiating cells surrounded by undifferentiated progenitors, ensuring continuous neurogenesis without exhausting the progenitor pool.

Key Takeaways

Notch signaling is a juxtacrine cell-cell communication pathway that controls cell fate decisions in neurogenesis through direct membrane contact.
The pathway involves proteolytic cleavage of Notch receptors by ADAM proteases and γ-secretase, releasing NICD that acts as a transcription factor.
Notch maintains neural stem/progenitor cells by repressing proneural genes through Hes/Hey transcription factors.
Lateral inhibition is the core mechanism by which Notch selects cells for differentiation while preserving the progenitor pool.
Notch signaling operates in both embryonic and adult neurogenesis, maintaining quiescence and regulating activation of adult neural stem cells.
The pathway is context-dependent and dynamic, not a simple on/off switch; outcomes depend on signal strength, duration, and cellular state.
Experimental tools include genetic models, γ-secretase inhibitors like DAPT, reporter systems, and live imaging, each with specific limitations that must be controlled for.